46 results
Type of content
News Remove News filter
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020 -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020 -
List item
News: Authorised uses of cancer medicine Yondelis unchanged following review of new data
CHMP, Last updated: 24/07/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019 -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019 -
List item
Press release: New measures to avoid potentially fatal dosing errors with methotrexate for inflammatory diseases
CHMP, Last updated: 23/08/2019 -
List item
Press release: Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
CHMP, Last updated: 20/03/2019 -
List item
Press release: Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities
CHMP, Last updated: 01/02/2019 -
List item
Press release: No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life
CHMP, Last updated: 23/01/2019 -
List item
Press release: Omega-3 fatty acid medicines no longer considered effective in preventing heart disease
CHMP, Last updated: 14/12/2018 -
List item
Press release: EMA recommends aligning doses of metamizole medicines and their use during pregnancy and breastfeeding
CHMP, Last updated: 14/12/2018 -
List item
Press release: Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics
CHMP, Last updated: 16/11/2018 -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
CHMP, Last updated: 01/06/2018 -
List item
Press release: Eye injuries in people and dogs when using Osurnia ear gel for dogs
CVMP, Last updated: 20/04/2018 -
List item
Press release: Updated measures for pregnancy prevention during retinoid use
CHMP, Last updated: 23/03/2018 -
List item
Press release: Defect with Buccolam oral syringes
CHMP, Last updated: 15/01/2018 -
List item
Press release: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage
CHMP, Last updated: 10/11/2017 -
List item
Press release: Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B
CHMP, Last updated: 16/12/2016